icon-    folder.gif   Conference Reports for NATAP  
 
  Presented at the 22nd Conference of the Asian Pacific Association for the Study of the Liver (APASL)
Taipei, Taiwan
February 16-19, 2012
Back grey_arrow_rt.gif
 
 
 
Five Years of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Infection Is Associated with Sustained Viral Suppression and Significant Regression of Fibrosis and Cirrhosis
 
 
  Reported by Jules Levin
22nd Congress of the Asian Pacific Association for the Study of the Liver
(APASL) Feb 16-19, 2012;
Taipei, Taiwan
 
E Gane1, N Tsai2, F Weilert3, M Buti4, IM Jacobson5,
MK Washington6, BN Bekele7, JD Bornstein7, JF Flaherty7,
JG McHutchison7, P Marcellin8
1Auckland City Hospital, Auckland, New Zealand; 2University of Hawaii at Manoa, Honolulu, HI, USA;
3Waikato Hospital, Hamilton, New Zealand; 4Hospital General Universitari Vall d'Hebron and Ciberehd, Barcelona, Spain;
5Medical College of Cornell University, New York, NY; USA; 6Vanderbilt
University, Nashville, TN, USA;
7Gilead Sciences Inc., Foster City, CA, USA; 8Hopital Beaujon, Clichy, France

APASL1.gif

APASL2.gif

APASL3.gif

APASL4.gif

APASL5.gif

APASL6.gif

APASL7.gif

APASL8.gif